Catalyst
Slingshot members are tracking this event:
Celgene Settles REVLIMID Patent Litigation with Natco Pharma Ltd. of India, Natco's U.S. partner, Arrow International Limited, and Arrow's parent company, Watson Laboratories, Inc. (a wholly-owned subsidiary of Allergan plc)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CELG |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 22, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Revlimid, Patent, Litigation, Settlement, Lenalidomide
